Cebranopadol: a first in-class example of a nociceptin/orphanin FQ receptor and opioid receptor agonist

被引:41
|
作者
Lambert, D. G. [1 ]
Bird, M. F. [1 ]
Rowbotham, D. J. [1 ]
机构
[1] Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Div Anaesthesia Crit Care & Pain Management, Leicester LE2 7LX, Leics, England
关键词
KNOCK-OUT MICE; MORPHINE-TOLERANCE; DRUG-ABUSE; DEPENDENCE; NOP; PEPTIDE; TARGET;
D O I
10.1093/bja/aeu332
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:364 / 366
页数:3
相关论文
共 50 条
  • [31] Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress
    Green, Megan K.
    Devine, Darragh P.
    NEUROPEPTIDES, 2009, 43 (06) : 507 - 514
  • [32] 3D-QSAR, homology modeling, and molecular docking studies on spiropiperidines analogues as agonists of nociceptin/orphanin FQ receptor
    Liu, Ming
    He, Lin
    Hu, Xiaopeng
    Liu, Peiqing
    Luo, Hai-Bin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7004 - 7010
  • [33] Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
    Shen, Qianwei
    Deng, Yulin
    Ciccocioppo, Roberto
    Cannella, Nazzareno
    FRONTIERS IN PSYCHIATRY, 2017, 8
  • [34] Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study
    Gozzi, Matteo
    Malfacini, Davide
    Albanese, Valentina
    Pacifico, Salvatore
    Preti, Delia
    Guerrini, Remo
    Calo, Girolamo
    Ciancetta, Antonella
    RSC MEDICINAL CHEMISTRY, 2025, 16 (04):
  • [35] In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cells
    Bird, Mark F.
    Hebbes, Christopher P.
    Tamang, Anushuya
    Willets, Jonathon Mark
    Thompson, Jonathan P.
    Guerrini, Remo
    Calo, Girolamo
    Lambert, David G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (17) : 2298 - 2314
  • [36] A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates
    Ding, Huiping
    Kiguchi, Norikazu
    Yasuda, Dennis
    Daga, Pankaj R.
    Polgar, Willma E.
    Lu, James J.
    Czoty, Paul W.
    Kishioka, Shiroh
    Zaveri, Nurulain T.
    Ko, Mei-Chuan
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (456)
  • [37] C7β-Methyl Analogues of the Orvinols: The Discovery of Kappa Opioid Antagonists with Nociceptin/Orphanin FQ Peptide (NOP) Receptor Partial Agonism and Low, or Zero, Efficacy at Mu Opioid Receptors
    Cueva, Juan Pablo
    Roche, Christopher
    Ostovar, Mehrnoosh
    Kumar, Vinod
    Clark, Mary J.
    Hillhouse, Todd M.
    Lewis, John W.
    Traynor, John R.
    Husbands, Stephen M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (10) : 4242 - 4249
  • [38] Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
    Arcuri, Ludovico
    Novello, Salvatore
    Frassineti, Martina
    Mercatelli, Daniela
    Pisano, Clarissa Anna
    Morella, Ilaria
    Fasano, Stefania
    Journigan, Blair V.
    Meyer, Michael E.
    Polgar, Willma E.
    Brambilla, Riccardo
    Zaveri, Nurulain T.
    Morari, Michele
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (05) : 782 - 796
  • [39] Roles of μ-Opioid Receptors and Nociceptin/Orphanin FQ Peptide Receptors in Buprenorphine-Induced Physiological Responses in Primates
    Cremeans, Colette M.
    Gruley, Erin
    Kyle, Donald J.
    Ko, Mei-Chuan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 343 (01) : 72 - 81
  • [40] A subset of nociceptin/orphanin FQ receptor-expressing neurons in the anterior hypothalamic area, as revealed in mice with lacZ reporter gene
    Houtani, T
    Ikeda, M
    Kase, M
    Sato, K
    Sakuma, S
    Kakimoto, S
    Ueyama, T
    Munemoto, Y
    Takeshima, H
    Sugimoto, T
    NEUROSCIENCE LETTERS, 2003, 335 (03) : 217 - 219